Nox4-SH3YL1 complex is involved in diabetic nephropathy.

Area of Science:

• Nephrology
• Molecular Biology
• Pathogenesis of Kidney Disease

Background:

• Oxidative stress from Nox4-derived hydrogen peroxide contributes to chronic kidney diseases (CKDs), including diabetic nephropathy (DN).
• SH3 domain-containing Ysc84-like 1 (SH3YL1) is identified as a cytosolic activator of Nox4.

Purpose of the Study:

• To investigate the role of SH3YL1 in the pathogenesis of diabetic nephropathy.
• To determine the therapeutic potential of targeting the SH3YL1-Nox4 interaction in DN.

Main Methods:

• Established streptozotocin-induced type 1 diabetic mouse models with whole-body SH3YL1 knockout (KO) and podocyte-specific SH3YL1 conditional KO (Nphs2-Cre/SH3YL1^fl/fl).
• Assessed markers of fibrosis, inflammatory cytokines, oxidative stress, and podocyte loss in diabetic mice.
• Measured SH3YL1 protein levels in human DN patient samples.

Main Results:

• SH3YL1 knockout in mice significantly suppressed fibrosis markers, inflammatory cytokines, oxidative stress, and podocyte loss in diabetic conditions.
• Increased SH3YL1 protein levels were observed in patients with diabetic nephropathy.
• The SH3YL1-Nox4 complex was implicated in renal inflammation and fibrosis development.

Conclusions:

• SH3YL1 plays a critical role in the development of diabetic nephropathy through the Nox4 pathway.
• Targeting SH3YL1 may offer a novel therapeutic strategy for managing diabetic kidney disease.